Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/ASO.2006.08.014
Annals of Surgical Oncology 13:651-658 (2006)
© 2006 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Duijnhoven, F. H.
Right arrow Articles by Tollenaar, R. A. E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Duijnhoven, F. H.
Right arrow Articles by Tollenaar, R. A. E. M.

Original Article

Factors Influencing the Local Failure Rate of Radiofrequency Ablation of Colorectal Liver Metastases

Fredericke H. van Duijnhoven, MD, PhD1, Maarten C. Jansen, MD2, Jan M. C. Junggeburt, PhD1, Richard van Hillegersberg, MD, PhD3, Arjen M. Rijken, MD, PhD4, Frits van Coevorden, MD, PhD5, Joost R. van der Sijp, MD, PhD6, Thomas M. van Gulik, MD, PhD2, Gerrit D. Slooter, MD, PhD7, Joost M. Klaase, MD, PhD8, Hein Putter, PhD1 and Rob A. E. M. Tollenaar, MD, PhD1

1 Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands
2 Department of Surgery, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
3 Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
4 Department of Surgery, Amphia Ziekenhuis, Molengracht 21, 4818 CK Breda, The Netherlands
5 Department of Surgery and Radiology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Ziekenhuis, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
6 Department of Surgery, VU Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
7 Department of Surgery, Maxima Medical Center, De Run 4600, 5504 DB Veldhoven, The Netherlands
8 Department of Surgery, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER Enschede, The Netherlands

Correspondence: Address correspondence and reprint requests to: F. H. van Duijnhoven; E-mail: f.h.van_duijnhoven{at}lumc.nl.

Background: The prognosis of patients with colorectal cancer is poor, especially when there is distant metastatic disease. Local ablation of tumor by radiofrequency ablation (RFA) has emerged as a safe and effective new treatment modality, but its long-term efficacy may be hindered by renewed local tumor growth at the site of RFA. The objectives of this study were to identify risk factors for local RFA failure and to define exclusion criteria for RFA treatment of colorectal liver metastases.

Methods: A total of 199 lesions in 87 patients were ablated with RFA. Factors influencing local failure rates were identified and compared with data from the literature.

Results: The local failure rate was 47.2%, and the average time to local disease progression was 6.5 months. Factors that significantly correlated with increased failure rates were metachronous occurrence of liver metastases, large mean lesion size, and central tumor location.

Conclusions: Because accurate electrode placement is pivotal in achieving adequate tumor necrosis, RFA should not be performed percutaneously when electrode placement is impaired. We suggest that lesions >5 cm and lesions located near great vessels or adjacent organs should be treated with open RFA, thus allowing vascular inflow occlusion and complete mobilization of the liver. Lesions that are difficult to reach by electrodes should be approached by an open procedure.

Key Words: Liver metastases • Radio frequency ablation • Local tumor control • Colorectal cancer




This article has been cited by other articles:


Home page
Ann OncolHome page
L. B. J. van Iersel, H. Gelderblom, A. L. Vahrmeijer, E. L. van Persijn van Meerten, F. G. J. Tijl, H. Putter, H. H. Hartgrink, P. J. K. Kuppen, J. W. R. Nortier, R. A. E. M. Tollenaar, et al.
Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients
Ann. Onc., June 1, 2008; 19(6): 1127 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Mulier, Y. Ni, J. Jamart, L. Michel, G. Marchal, and T. Ruers
Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?
Ann. Surg. Oncol., January 1, 2008; 15(1): 144 - 157.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
T. M. Pawlik, R. D. Schulick, and M. A. Choti
Expanding Criteria for Resectability of Colorectal Liver Metastases
Oncologist, January 1, 2008; 13(1): 51 - 64.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society of Surgical Oncology.